Prevalence of hypoparathyroidism in beta thalassemia major

Khalida Parveen Basha N., Beena Shetty, U. V. Shenoy

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: The aim of this study was to assess the parathyroid functions and bone mineral density(BMD) in patients with beta thalassemia and to correlate them with serum ferritin, calcium, phosphorus and alkaline phosphatase levels. Materials and Methods: This is a case control study which was done on 55 subjects (40 cases and 15 controls) in the age group of 2-18 years. The cases included were with confirmed diagnosis of beta thalassemia major, more than ten blood transfusions and serum ferritin levels >2000 μg/L irrespective of chelation therapy. Results: Significant hypoparathyroidism observed along with low bone mineral density levels in beta thalassemia patients. (p < 0.01) A significant decrease in serum calcium level was seen in cases when compared to controls, where as the levels of both serum phosphorus and alkaline phosphatase levels increased in cases when compared to controls. Conclusion: BMD and PTH levels are very useful tools for diagnosing HPT. As a routine, in beta thalassemia major, screening for vitamin D deficiency and hypocalcemia should be done in second decade of life and as a preventive measure they should be supplemented with calcium and vitamin D to prevent hypocalcemic tetany, to facilitate bone growth and to prevent fractures.

Original languageEnglish
Pages (from-to)24-26
Number of pages3
JournalJournal of Clinical and Diagnostic Research
Volume8
Issue number2
DOIs
Publication statusPublished - 03-02-2014

Fingerprint

Hypoparathyroidism
beta-Thalassemia
Bone
Minerals
Ferritins
Calcium
Vitamin D
Bone Density
Phosphorus
Alkaline Phosphatase
Serum
Chelation
Chelation Therapy
Tetany
Screening
Blood
Vitamin D Deficiency
Hypocalcemia
Bone Development
Blood Transfusion

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Basha N., Khalida Parveen ; Shetty, Beena ; Shenoy, U. V. / Prevalence of hypoparathyroidism in beta thalassemia major. In: Journal of Clinical and Diagnostic Research. 2014 ; Vol. 8, No. 2. pp. 24-26.
@article{d1b4700746024b0fa5463c617de2d9b4,
title = "Prevalence of hypoparathyroidism in beta thalassemia major",
abstract = "Introduction: The aim of this study was to assess the parathyroid functions and bone mineral density(BMD) in patients with beta thalassemia and to correlate them with serum ferritin, calcium, phosphorus and alkaline phosphatase levels. Materials and Methods: This is a case control study which was done on 55 subjects (40 cases and 15 controls) in the age group of 2-18 years. The cases included were with confirmed diagnosis of beta thalassemia major, more than ten blood transfusions and serum ferritin levels >2000 μg/L irrespective of chelation therapy. Results: Significant hypoparathyroidism observed along with low bone mineral density levels in beta thalassemia patients. (p < 0.01) A significant decrease in serum calcium level was seen in cases when compared to controls, where as the levels of both serum phosphorus and alkaline phosphatase levels increased in cases when compared to controls. Conclusion: BMD and PTH levels are very useful tools for diagnosing HPT. As a routine, in beta thalassemia major, screening for vitamin D deficiency and hypocalcemia should be done in second decade of life and as a preventive measure they should be supplemented with calcium and vitamin D to prevent hypocalcemic tetany, to facilitate bone growth and to prevent fractures.",
author = "{Basha N.}, {Khalida Parveen} and Beena Shetty and Shenoy, {U. V.}",
year = "2014",
month = "2",
day = "3",
doi = "10.7860/JCDR/2014/6672.3997",
language = "English",
volume = "8",
pages = "24--26",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "2",

}

Prevalence of hypoparathyroidism in beta thalassemia major. / Basha N., Khalida Parveen; Shetty, Beena; Shenoy, U. V.

In: Journal of Clinical and Diagnostic Research, Vol. 8, No. 2, 03.02.2014, p. 24-26.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prevalence of hypoparathyroidism in beta thalassemia major

AU - Basha N., Khalida Parveen

AU - Shetty, Beena

AU - Shenoy, U. V.

PY - 2014/2/3

Y1 - 2014/2/3

N2 - Introduction: The aim of this study was to assess the parathyroid functions and bone mineral density(BMD) in patients with beta thalassemia and to correlate them with serum ferritin, calcium, phosphorus and alkaline phosphatase levels. Materials and Methods: This is a case control study which was done on 55 subjects (40 cases and 15 controls) in the age group of 2-18 years. The cases included were with confirmed diagnosis of beta thalassemia major, more than ten blood transfusions and serum ferritin levels >2000 μg/L irrespective of chelation therapy. Results: Significant hypoparathyroidism observed along with low bone mineral density levels in beta thalassemia patients. (p < 0.01) A significant decrease in serum calcium level was seen in cases when compared to controls, where as the levels of both serum phosphorus and alkaline phosphatase levels increased in cases when compared to controls. Conclusion: BMD and PTH levels are very useful tools for diagnosing HPT. As a routine, in beta thalassemia major, screening for vitamin D deficiency and hypocalcemia should be done in second decade of life and as a preventive measure they should be supplemented with calcium and vitamin D to prevent hypocalcemic tetany, to facilitate bone growth and to prevent fractures.

AB - Introduction: The aim of this study was to assess the parathyroid functions and bone mineral density(BMD) in patients with beta thalassemia and to correlate them with serum ferritin, calcium, phosphorus and alkaline phosphatase levels. Materials and Methods: This is a case control study which was done on 55 subjects (40 cases and 15 controls) in the age group of 2-18 years. The cases included were with confirmed diagnosis of beta thalassemia major, more than ten blood transfusions and serum ferritin levels >2000 μg/L irrespective of chelation therapy. Results: Significant hypoparathyroidism observed along with low bone mineral density levels in beta thalassemia patients. (p < 0.01) A significant decrease in serum calcium level was seen in cases when compared to controls, where as the levels of both serum phosphorus and alkaline phosphatase levels increased in cases when compared to controls. Conclusion: BMD and PTH levels are very useful tools for diagnosing HPT. As a routine, in beta thalassemia major, screening for vitamin D deficiency and hypocalcemia should be done in second decade of life and as a preventive measure they should be supplemented with calcium and vitamin D to prevent hypocalcemic tetany, to facilitate bone growth and to prevent fractures.

UR - http://www.scopus.com/inward/record.url?scp=84893483530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893483530&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2014/6672.3997

DO - 10.7860/JCDR/2014/6672.3997

M3 - Article

AN - SCOPUS:84893483530

VL - 8

SP - 24

EP - 26

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 2

ER -